Material Type: Saline laxatives Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

Material Type: Personal insect repellents, aerosols Industry: Pesticide and other agricultural chemical manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

多肽化妆品原料领军企业，深耕医药多肽自主研发创新。公司成立于2015年，依托全球领先的全固相合成多肽开发与生产工艺，从事多肽化妆品原料和多肽医药产品及相关服务的研发、生产及销售业务。2020-2022年，在多肽化妆品原料与多肽医药的双轮驱动下，公司业绩持续高增，22年营收同比增49.06%至2.13亿元，归母净利同比增86.11%至0.72亿元。 

沙东(又名默克，MSD)是全球制药巨头之一，总部位于美国新泽西州，是一家以科研为本，致力于研究、开发和销售创新医药产品的跨国制药公司。默沙东引领多维度医疗领域新药研发，其业务范围覆盖了肿瘤、疫苗、传染病、心血管疾病、动物保健等多个疾病领域；其中在疫苗领域更是与葛兰素史克(GSK)、赛诺菲、辉瑞并称“全球四大疫苗巨头”。默沙东研发的药物在全球市场广泛销售和使用，代表产品包括抗肿瘤领域的 PD-1 靶向抑制剂（帕博丽珠单抗，K 药）、疫苗领域的宫颈癌疫苗和乙肝疫苗、肝癌领域的仑伐替尼、卵巢癌领域的利普卓、以及抗传染病领域的埃博拉疫苗和新冠药物新冠口服药等。

Equipment Type: Ultrasonic equipment, excluding medical and dental Industry: All other electrical equipment and component manufacturing The equipment described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the equipment from other similar equipment. The equipment descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each equipment is categorized. The U.S. Census manufacturing industry descriptions for equipment are listed below

Material Type: Topical antibiotic preparations Industry: Pharmaceutical and medicine manufacturing The Material described in this report are primarily defined by its title since the title is generally long and includes most of the criteria used to differentiate the Material from other similar Material. The Material descriptions are sourced from the U.S. Census. Additionally descriptions can be collected from the manufacturing industry descriptions that each Material is categorized. The U.S. Census manufacturing industry descriptions for Material are listed below

2021年我国EGFR外显子20突变非小细胞肺癌新发人数达3.2万人。2021年我国肺癌新发患者达828万人，其中非小细胞肺癌占比达90%，约74.5万人;局部晚期及晚期比例达85%，期及IV期非小细胞肺癌新发患者人数达63万人;我国EGFR突变率达50%，EGFR突变非小细胞肺癌人数约315万人;外显子20突变率达10%，约3.2万人。EGFRex20insNSCLC一线治疗:国内外指南推荐参考驱动基因阴性NSCLC，尚未有效针对性治疗手段EGFRex20insNSCLC二线治疗:两款药物上市，分别是强生的Rybrevant和武田的莫博替尼，其中莫博替尼于2023年1月获NMPA批准上市。